 

FINAL DIAGNOSIS: ..
PART 1: WSEGMENTAL MASTECTOMY —

INFILT
‘ RATING DUCTAL CARCI , NOS TYPE, MODERATELY DIFFERENTIATED.

.5 CM (GROSS MEASUREMEN , N TT
NUCLEAR GRADE 2, MITOSIS 2; OVERALL GRADE 2I3). T) O INGHAM SCORE 6/9 (TUBULE 2,

A.
B.
S: 33é¥ﬁp€fgai%%Tﬁigﬁﬁ?§:LIE I’ESEEIEEIF
E
F
G

25% OF THE TOTAL TUMOR VOLUME AND IS PRESENT IN ASSOCIATION WIT

FIBROCYSTIC CHANGES DUCTAL EPITHELIAL HYPERPLASI
. A, COLUMNAR CELL HYP
ATYPICAL DUCTAL HYPERPLASIA, SCLEROSING ADENOSIS, AND PREVIOUS BIOPSY SIITFELSSKINGES.

ESTROGEN RECEPTOR POSITIVE. PR
SCORE 1+), CROSS REFER OGESTERONE RECEPTOR POSITIVE, HER-ZINEU NEGATIVE (IHC

PART 2: BREAST, LEFT , LATERAL MARGIN, EXCISION -
A. NO IN-SITU OR INVASIVE CARCINOMA IDENTIFIED.

B. FIBROCYSTIC CHANGES, DUCTAL EPITHELIA
COLUMNAR CELL CHANGE. L HYPERPLASIA, SCLEROSING ADENOSIS, AND

PART 3: SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY —
ONE BENIGN LYMPH NODE, NO TUMOR SEEN (0/1).
PART 4: SENTINEL LYMPH NODE #2, LEFT AXILLA, BIUFST —
A. ONE OUT OF TWO LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (1/2), THE METASTATIC
FOCUS MEASURES 1 CM (ON GLASS SLIDE).
B. EXTRACAPSULAR EXTENSION IS IDENTIFIED. lob ~ 0 , 3

‘ ‘ ‘ 96.“ A! N0 co
PART 5: SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY — 0 W/ “W “1"” 7 ' 5 ‘05 /3

Two BENIGN LYMPH NODES, NO TUMOR SEEN (0/2). ﬁn,- W N05 a 3’0. 9 3/12/11 p
CASE SYNOPSIS:

SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST

LATERALITY: Left
PROCEDURE: Segmental
LOCATION: Not speciﬁed
SIZE OF TUMOR: Maximum dimension invasive component: 2.5 cm
MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI:
No

TUMOR TYPE (invaslve component):
Ductal adenocarcinoma, NOS

NOTTINGHAM SCORE: Nuclear grade: 2
TubuIe formation. 2 - IIUID:A3CDF0514162—47EC-BE8A-1519A5564518
I“::I:.::?:;:::°:;f. 6 Re acted
Nottingham grade (1, 2, 3): 2 III IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIHHHIIIIIIII
ANG'OLYMPHATIC INVASION: No II I IIII I III I I I IIIIIIIIIIIIIIIII I II IIIIIIIIIIIIIII III
”ERMALLYMPHAT'c'NVAS'°”‘ N° IIIlIIlIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
CALCIFICATION: No
TUMOR TYPE, IN SITU: gribriform
oIid

DCIS admixed with invasive carcinoma

Percent of tumor occupied by in situ component: 25 %
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:

No

Distance of invasive tumor to closest margin: 1 mm
SURG MARGINS INVOLVED BY IN SITU COMPONENT:

No
Distance of in situ disease to closest margin: 1 mm
PAGET'S DISEASE OF NIPPLE: No
LYMPH NODES POSITIVE: 1
LYMPH NODES EXAMINED: 5
METHODIS) OF LYMPH NODE EXAMINATION: :
HIE Staln mm M.“ ",mmsrorv

SENTINEL NODE METASTASIS: Yes
ONLY KERATIN POSITIVE CELLS ARE PRESENT:

 

No
SIZE OF NODAL METASTASES: Diameter of largest lymph node metaswsus. IU mm
LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION:
Yes
METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE):
No

SKIN INVOLVED (ULCERATION): No
NON-NEOPLASTIC BREAST TISSUE: ADH, FCD
T STAGE, PATHOLOGIC: pT2

N STAGE, PATHOLOGIC: pN1

ll QTAGE DATLIAI hftlh- ally

 

